Amphastar Pharmaceuticals(AMPH.US) Director Sells US$20,836.95 in Common Stock
$Amphastar Pharmaceuticals(AMPH.US)$ Director Petersen Floyd F. sold 500 shares of common stock on May 1, 2024 at an average price of $41.6739 for a total value of $20,836.95.Source: Announcement What
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 8, 2024
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 30, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2024 ended March 31, 2024, a
Top Midday Stories: Shares of Eli Lilly, HSBC Get Post-Earnings Bump; BBVA Exploring Merger With Sabadell; FTC Disputes 300 'Junk' Patent Listings
All three major Wall Street indexes were down in late-morning trading Tuesday in the wake of higher-than-expected employment cost data and ahead of the Federal Open Market Committee's decision on rate
FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications
10:49 AM EDT, 04/30/2024 (MT Newswires) -- FTC Challenging 'Junk' Patent Listings for Ozempic, Victoza, Other Medications Price: 129.77, Change: +2.89, Percent Change: +2.28
Institutional Investors Control 67% of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) and Were Rewarded Last Week After Stock Increased 5.6%
Key Insights Given the large stake in the stock by institutions, Amphastar Pharmaceuticals' stock price might be vulnerable to their trading decisions A total of 8 investors have a majority stake in
Amphastar Pharmaceuticals Poised for Growth: Strong Generic Pipeline and Strategic Marketing Drive Buy Rating
323 drugs, hurry up! America is facing the biggest “drug shortage” in history...
The US now seems to be facing an unprecedented “drug shortage”...
Amphastar Pharmaceuticals (NASDAQ:AMPH) Shareholders YoY Returns Are Lagging the Company's 66% Three-year Earnings Growth
Analysts Have Conflicting Sentiments on These Healthcare Companies: Amphastar Pharmaceuticals (AMPH), Ascendis Pharma (ASND) and AMN Healthcare Services (AMN)
Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies
At the Needham Healthcare Conference, Amphastar Pharmaceuticals Inc (NASDAQ:AMPH) highlighted why they remain excited about Baqsimi, the inhaled glucagon product for severe hypoglycemia. Amphastar Pha
Needham: Reiterates that Amphastar Pharma (AMPH.US) holds the rating.
Needham: Reiterates that Amphastar Pharma (AMPH.US) holds the rating.
Needham Reiterates Hold on Amphastar Pharma
Needham analyst Serge Belanger reiterates Amphastar Pharma (NASDAQ:AMPH) with a Hold.
Needham Sticks to Its Hold Rating for Amphastar Pharmaceuticals (AMPH)
Amphastar Pharmaceuticals (NASDAQ:AMPH) Offers Savvy Value Investors a Window of Opportunity
Amphastar Pharmaceuticals (AMPH) Stock Moves -1%: What You Should Know
If EPS Growth Is Important To You, Amphastar Pharmaceuticals (NASDAQ:AMPH) Presents An Opportunity
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even companies that have no revenue, no profit, and a record of falling short, can manage
Amphastar Pharmaceuticals(AMPH.US) Director Sells US$21,714.15 in Common Stock
$Amphastar Pharmaceuticals(AMPH.US)$ Director Petersen Floyd F. sold 500 shares of Common Stock on Apr 1, 2024 at an average price of $43.4283 for a total value of $21,714.15.Source: Announcement What
Amphastar Pharmaceuticals to Present at the 23rd Annual Needham Virtual Healthcare Conference
RANCHO CUCAMONGA, CA / ACCESSWIRE / April 1, 2024 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, CFO, Tony Marrs, EVP of Regulatory Affairs and Clinical Operations,
Amphastar Pharmaceuticals (AMPH) Stock Sinks As Market Gains: What You Should Know
Amphastar Pharmaceuticals (NASDAQ:AMPH) Seems To Use Debt Quite Sensibly
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the permanent loss of capital.' It's only natural to consider a company's balance sheet wh
No Data